United States · FDA National Drug Code directory

Camptosar

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0009-0112_6f05fe24-191a-4273-ad62-4ab6b5324062
Product NDC
0009-0112
Form
INJECTION, SOLUTION
Composition / generic term
irinotecan hydrochloride
Labeler
Pharmacia & Upjohn Company LLC
Marketing category
NDA
Marketing start / end (source format)
20241230
Source listing expiry
20271231

Source-listed ingredients

  • IRINOTECAN HYDROCHLORIDE — 20 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-0112-05) / 5 mL in 1 VIAL, SINGLE-DOSE · 0009-0112-05

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →